A protein previously thought to solely break down fat for energy also plays a crucial role in maintaining the health of fat cells. This protein, hormone-sensitive lipase (HSL), was found operating within the nucleus of fat cells, where it helps regulate genetic activity. This discovery challenges decades of scientific understanding about HSL and fat metabolism.
Researchers at the Institute of Cardiovascular and Metabolic Diseases (I2MC) at the University of Toulouse published these findings in *Cell Metabolism*. The study addresses a long-standing paradox: individuals lacking HSL do not become obese. Instead, they develop lipodystrophy, a condition characterized by a dangerous loss of healthy fat tissue. This new understanding suggests that HSL's nuclear function is vital for maintaining healthy adipose tissue.
Fat cells, or adipocytes, are not merely storage units for calories. They are active participants in the body's energy regulation. HSL's known role involves breaking down triglycerides into fatty acids when the body requires fuel. The new research indicates that HSL in the nucleus associates with other proteins to maintain optimal adipose tissue and adipocyte health. This includes regulating mitochondrial activity and the extracellular matrix, both critical for tissue function.
The study found that HSL's behavior differs depending on its location within the cell. On lipid droplets, HSL acts as an enzyme to release stored fat. In the nucleus, it functions as a regulator, helping to maintain healthy adipose tissue. The amount of nuclear HSL changes with the body's metabolic state. During fasting, HSL moves out of the nucleus to mobilize fat stores. In obese mice fed a high-fat diet, nuclear HSL levels increased. This movement is controlled by signaling pathways involving TGF-β and SMAD3, molecules linked to inflammation and metabolic disease.
This discovery helps explain why HSL deficiency leads to lipodystrophy rather than obesity. Without HSL in the nucleus, fat cells may lose their ability to maintain health and proper adipose tissue. This insight could lead to new approaches for treating metabolic disorders. Future therapies might focus on restoring the normal function of adipocytes and protecting the biological systems that maintain healthy fat tissue, rather than just reducing fat mass.
Obesity rates continue to rise globally, increasing the risk of various health issues. Understanding how proteins like HSL regulate fat cell health offers a new avenue for developing more targeted treatments for metabolic diseases. Adipose tissue is recognized as a complex endocrine organ that communicates with other body systems. Dysfunctional fat tissue can have widespread effects beyond weight gain.
Related stories
Constipation Drug May Slow Chronic Kidney Disease Progression
A clinical trial found that the common constipation drug lubiprostone may slow the progression of chronic kidney disease by altering gut bacteria and improving mitochondrial function.
Fat-Burning Protein Discovered Inside Cell Nucleus
A fat-burning protein, hormone-sensitive lipase (HSL), has been found to control fat cell health from inside the nucleus, challenging previous obesity research.
New Drug Shows Promise for Obesity and Type 2 Diabetes
A new "Trojan horse" drug for obesity and type two diabetes shows promise in mouse studies, delivering a metabolic enhancer directly to cells for improved weight loss and blood sugar control.